Home/Simphotek/Karl Beeson

KB

Karl Beeson

Co-founder and Vice President of Technology

Therapeutic Areas

Simphotek Pipeline

Drug	Indication	Phase
Dosie™ for I-PDT	Malignant Pleural Mesothelioma	Pre-clinical/Development

Leadership Team at Simphotek

Gene (Evgueni) Parilov

Co-founder and Chief Technology Officer (CTO)

Co-founder and Chief Scientific Officer (CSO)

View full Simphotek profile